Blood test aims to catch silent pancreatic cancer in new diabetics
NCT ID NCT05188573
Summary
This study aimed to test a new blood test designed to find hidden pancreatic cancer in people recently diagnosed with type 2 diabetes. The plan was to enroll 10,000 adults aged 50+ with new diabetes. If the blood test suggested cancer, participants would get an MRI scan to check. The trial was withdrawn and did not enroll any participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bluestar Genomics, Inc.
San Diego, California, 92121, United States
Conditions
Explore the condition pages connected to this study.